Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Feb. 1 to 5, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Feb. 1 to 5, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
United States Sees Continued Drop in New COVID-19 Cases
FRIDAY, Feb. 5, 2021 (HealthDay News) — New COVID-19 case counts are now steadily dropping across the United States, as the worst of the latest surge in the pandemic seems to be subsiding.
J&J Submits EUA Request for COVID-19 Vaccine
FRIDAY, Feb. 5, 2021 (HealthDay News) — A U.S. Food and Drug Administration committee will meet on Feb. 26 to discuss Emergency Use Authorization of the COVID-19 vaccine candidate from Janssen Biotech, the agency announced Thursday.
Racial Disparities Seen in Mental Health Conditions During COVID-19
FRIDAY, Feb. 5, 2021 (HealthDay News) — Mental health conditions and substance use are common during the COVID-19 pandemic, especially among racial- and ethnic-minority groups, according to research published in the Feb. 5 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Small Study Tests Colchicine for Moderate-to-Severe COVID-19
FRIDAY, Feb. 5, 2021 (HealthDay News) — For patients with moderate-to-severe COVID-19, colchicine reduces the length of supplemental oxygen therapy and hospitalization, according to a study published online Feb. 4 in RMD Open.
First Federal COVID-19 Vaccination Sites to Open in California
THURSDAY, Feb. 4, 2021 (HealthDay News) — The first COVID-19 vaccination sites run by the federal government will be opened in California as the Biden administration employs yet another tool to try to tame the COVID-19 pandemic.
High Efficacy Reported for Sputnik V COVID-19 Vaccine
THURSDAY, Feb. 4, 2021 (HealthDay News) — A heterologous recombinant adenovirus-based vaccine, Gam-COVID-Vac (Sputnik V), has 91.6 percent efficacy against COVID-19, according to a study published online Feb. 2 in The Lancet.
Companies Developing Vaccines Against New Coronavirus Variants
THURSDAY, Feb. 4, 2021 (HealthDay News) — As concerns mount about mutations that could make the new coronavirus more difficult to fight, two companies say they are working to develop new vaccines against emerging variants of the virus that causes COVID-19.
COVID-19 Outcomes Worse for Persons Living With Diagnosed HIV
THURSDAY, Feb. 4, 2021 (HealthDay News) — Persons living with HIV who are diagnosed with COVID-19 are more likely to require hospitalization and to die, according to a study published online Feb. 3 in JAMA Network Open.
Racial Disparities Seen in Excess Mortality Early in Pandemic
Significant Association ID"d Between Hepatitis C, Overactive Bladder .jpg)
Study Looks at Barriers to Initiation of Rotavirus Vaccine 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Obstructive Sleep Apnea Tied to Nearly Doubled Risk for Flu, COVID-19 in Childhood 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Physical Exams May Not Reliably Diagnose Pediatric Pneumonia .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
